Literature DB >> 9615865

Diversity of DNA topoisomerases I and inhibitors.

Y Pommier1.   

Abstract

The present review first describes the different type I topoisomerases found in eukaryotic cells: nuclear topoisomerase I (top1), topoisomerase 3 (top3), mitochondrial topoisomerase I and viral topoisomerases I. The second part of the review provides extensive information on the topoisomerase I inhibitors identified to date. These drugs can be grouped in two categories: top1 poisons and top1 suppressors. Both inhibit enzyme catalytic activity but top1 poisons trap the top1 catalytic intermediates ('cleavage complexes') while top1 suppressors prevent or reverse top1 cleavage complexes. The molecular interactions of camptothecin with the top1 cleavage complexes are discussed as well as the mechanisms of selective killing of cancer cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9615865     DOI: 10.1016/s0300-9084(98)80008-4

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  20 in total

1.  The mechanism of topoisomerase I poisoning by a camptothecin analog.

Authors:  Bart L Staker; Kathryn Hjerrild; Michael D Feese; Craig A Behnke; Alex B Burgin; Lance Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-08       Impact factor: 11.205

2.  Human topoisomerase I cleavage complexes are repaired by a p53-stimulated recombination-like reaction in vitro.

Authors:  Holger Stephan; Frank Grosse; Kent Søe
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

3.  Antifungal activity of eupolauridine and its action on DNA topoisomerases.

Authors:  Shabana I Khan; Alison C Nimrod; Mohammed Mehrpooya; John L Nitiss; Larry A Walker; Alice M Clark
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Pyridoxal 5'-phosphate inactivates DNA topoisomerase IB by modifying the lysine general acid.

Authors:  Jacqueline J Vermeersch; Serge Christmann-Franck; Leon V Karabashyan; Serge Fermandjian; Gilles Mirambeau; P Arsène Der Garabedian
Journal:  Nucleic Acids Res       Date:  2004-10-19       Impact factor: 16.971

5.  Structures of minimal catalytic fragments of topoisomerase V reveals conformational changes relevant for DNA binding.

Authors:  Rakhi Rajan; Bhupesh Taneja; Alfonso Mondragón
Journal:  Structure       Date:  2010-07-14       Impact factor: 5.006

6.  Molecular docking approach on the Topoisomerase I inhibitors series included in the NCI anti-cancer agents mechanism database.

Authors:  Antonino Lauria; Mario Ippolito; Anna Maria Almerico
Journal:  J Mol Model       Date:  2006-10-28       Impact factor: 1.810

Review 7.  Defining a genotoxic profile with mouse embryonic stem cells.

Authors:  Tae Moon Kim; Vivienne I Rebel; Paul Hasty
Journal:  Exp Biol Med (Maywood)       Date:  2013-03

8.  Ku80-deleted cells are defective at base excision repair.

Authors:  Han Li; Teresa Marple; Paul Hasty
Journal:  Mutat Res       Date:  2013-04-06       Impact factor: 2.433

9.  beta-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells.

Authors:  L Huang; A B Pardee
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.376

10.  Secondary metabolites as DNA topoisomerase inhibitors: A new era towards designing of anticancer drugs.

Authors:  Supriya Baikar; Nutan Malpathak
Journal:  Pharmacogn Rev       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.